Anika Therapeutics, Inc. (ANIK)
20.82
-0.18
(-0.83%)
USD |
NASDAQ |
Sep 04, 16:00
20.82
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Cash from Investing (Quarterly) : -1.28M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.28M |
| March 31, 2026 | -1.239M |
| December 31, 2025 | 0.198M |
| September 30, 2025 | -1.732M |
| June 30, 2025 | -0.539M |
| March 31, 2025 | 1.672M |
| December 31, 2024 | -1.307M |
| September 30, 2024 | -1.816M |
| June 30, 2024 | -3.403M |
| March 31, 2024 | -1.808M |
| December 31, 2023 | -1.84M |
| September 30, 2023 | -0.741M |
| June 30, 2023 | -1.457M |
| March 31, 2023 | -1.389M |
| December 31, 2022 | -2.529M |
| September 30, 2022 | -1.691M |
| June 30, 2022 | -1.94M |
| March 31, 2022 | -1.326M |
| December 31, 2021 | -1.24M |
| September 30, 2021 | -1.295M |
| June 30, 2021 | -2.317M |
| March 31, 2021 | 1.734M |
| December 31, 2020 | 16.81M |
| September 30, 2020 | 6.729M |
| June 30, 2020 | -2.299M |
| Date | Value |
|---|---|
| March 31, 2020 | -92.50M |
| December 31, 2019 | 41.02M |
| September 30, 2019 | 2.10M |
| June 30, 2019 | -1.516M |
| March 31, 2019 | -1.917M |
| December 31, 2018 | -2.581M |
| September 30, 2018 | -55.14M |
| June 30, 2018 | 7.26M |
| March 31, 2018 | 0.207M |
| December 31, 2017 | -0.724M |
| September 30, 2017 | -3.339M |
| June 30, 2017 | -7.992M |
| March 31, 2017 | -0.425M |
| December 31, 2016 | 0.345M |
| September 30, 2016 | -2.49M |
| June 30, 2016 | -2.951M |
| March 31, 2016 | -1.667M |
| December 31, 2015 | -12.94M |
| September 30, 2015 | -4.385M |
| June 30, 2015 | -6.896M |
| March 31, 2015 | -6.006M |
| December 31, 2014 | 12.62M |
| September 30, 2014 | -20.24M |
| June 30, 2014 | -0.4008M |
| March 31, 2014 | -0.2765M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 15.02M |
| MiMedx Group, Inc. | -0.635M |
| ABVC BioPharma, Inc. | -0.1015M |
| Enovis Corp. | -45.01M |
| Edwards Lifesciences Corp. | -193.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.684M |
| Cash from Financing (Quarterly) | -0.701M |
| Free Cash Flow | 0.562M |
| Free Cash Flow Per Share (Quarterly) | -0.1555 |
| Free Cash Flow to Equity (Quarterly) | -1.647M |
| Free Cash Flow to Firm (Quarterly) | -2.133M |
| Free Cash Flow Yield | 0.19% |